Tarsus Pharmaceuticals, Inc. financial data

Symbol
TARS on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
15440 Laguna Canyon Road, Irvine, CA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-K - Q4 2024 - Feb 25, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 589 % -42.7%
Quick Ratio 4.86 %
Debt-to-equity 49.5 % +79.2%
Return On Equity -46.7 % +37.1%
Return On Assets -31.2 % +46.3%
Operating Margin -65.9 % +92%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 38.4M shares +1.58%
Common Stock, Shares, Outstanding 38.3M shares +12.1%
Entity Public Float 996M USD +117%
Common Stock, Value, Issued 6K USD +20%
Weighted Average Number of Shares Outstanding, Basic 37.6M shares +28%
Weighted Average Number of Shares Outstanding, Diluted 37.6M shares +28%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 183M USD +949%
Research and Development Expense 53.4M USD +6.11%
General and Administrative Expense 57.9M USD +91%
Costs and Expenses 304M USD +89%
Operating Income (Loss) -121M USD +15.8%
Nonoperating Income (Expense) 5.02M USD -31%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -116M USD +15%
Earnings Per Share, Basic -3.07 USD/shares +33.6%
Earnings Per Share, Diluted -3.07 USD/shares +33.6%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 94.8M USD -57.8%
Marketable Securities, Current 197M USD +7778%
Accounts Receivable, after Allowance for Credit Loss, Current 46.8M USD +181%
Inventory, Net 2.62M USD -15.7%
Assets, Current 357M USD +39.3%
Property, Plant and Equipment, Net 2.31M USD +57.6%
Operating Lease, Right-of-Use Asset 552K USD -70.6%
Intangible Assets, Net (Excluding Goodwill) 8.33M USD +115%
Other Assets, Noncurrent 999K USD -34%
Assets 377M USD +42%
Employee-related Liabilities, Current 15.8M USD +19.5%
Liabilities, Current 80.6M USD +118%
Operating Lease, Liability, Noncurrent 0 USD -100%
Other Liabilities, Noncurrent 0 USD -100%
Liabilities 152M USD +123%
Accumulated Other Comprehensive Income (Loss), Net of Tax 179K USD
Retained Earnings (Accumulated Deficit) -360M USD -47.2%
Stockholders' Equity Attributable to Parent 225M USD +14%
Liabilities and Equity 377M USD +42%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -37.8M USD -72%
Net Cash Provided by (Used in) Financing Activities 109M USD +2070%
Net Cash Provided by (Used in) Investing Activities -102M USD -1005%
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 38.3M shares +12.1%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -31.2M USD -452%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 97.4M USD -56.7%
Interest Paid, Excluding Capitalized Interest, Operating Activities 868K USD +46.4%
Deferred Tax Assets, Valuation Allowance 88M USD +46.1%
Deferred Tax Assets, Gross 88.4M USD +44.9%
Operating Lease, Liability 608K USD -68.2%
Depreciation 685K USD -7.93%
Payments to Acquire Property, Plant, and Equipment 174K USD -48.8%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -115M USD +15.1%
Lessee, Operating Lease, Liability, to be Paid 800K USD -66.3%
Property, Plant and Equipment, Gross 4.29M USD +55.5%
Operating Lease, Liability, Current 608K USD +52.8%
Lessee, Operating Lease, Liability, to be Paid, Year Two 0 USD -100%
Lessee, Operating Lease, Liability, to be Paid, Year One 800K USD +14.1%
Operating Lease, Weighted Average Discount Rate, Percent 0.11 pure +10%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 30K USD -91%
Lessee, Operating Lease, Liability, to be Paid, Year Three 0 USD -100%
Deferred Tax Assets, Operating Loss Carryforwards 33.7M USD +30.1%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 4.75M USD +20.9%
Lessee, Operating Lease, Liability, to be Paid, Year Four 0 USD -100%
Additional Paid in Capital 585M USD +32.4%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 540K USD +306%
Deferred Tax Assets, Net of Valuation Allowance 354K USD -51.7%
Share-based Payment Arrangement, Expense 27.8M USD +40.3%
Interest Expense 3.65M USD +42%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%